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Abstract
Background: Bone Morphogenetic Protein (BMP) signaling pathways are involved in differentiation of stem cells into
diverse cell types, and thus BMPs can be used as main guidance molecules for in vitro differentiation of human stem cells.
Methodology/Principal Findings: We have analyzed the ability for inducing differentiation of the heterodimer BMP-2/BMP-
6 (BMP-2/6) compared to the homodimers BMP-2 or BMP-6, using human embryonic stem (hES) cells H9 as model system.
When incubated in a medium with high concentration of basic fibroblastic growth factor (FGF2), 100 ng/ml of human
recombinant BMPs induced morphological changes and differentiation of hES cells in 24 to 48 hours. After 5 days,
expression of differentiation markers was induced and quantified by quantitative PCR (qPCR) and flow cytometry. BMP-2/6
exhibited stronger activity for the induction of the expression of trophectodermal (CDX2) and endodermal (SOX17, GATA4,
AFP) markers than BMP-2 or BMP-6 homodimers. BMP-2/6 also induced the expression of BMPR2 gene more effectively than
BMP-2 or BMP-6 when used at the same concentration and time. Moreover, the percentage of cells expressing the surface
endodermal marker CXCR4 was also increased for the heterodimer when compared to both homodimers. BMP-2/6 was a
more potent activator of Smad-dependent (SMAD1/5) and Smad-independent signaling (mitogen-activated protein kinases
ERK and p38) than BMP-2 and BMP-6, and the activation of these pathways might play a role in its increased potency for
inducing hES cell differentiation.
Conclusions/Significance: Therefore, we conclude that BMP-2/6 is more potent than BMP-2 or BMP-6 for inducing
differentiation of hES cells, and it can be used as a more powerful substitute of these BMPs in in vitro differentiation guidance.
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Introduction
Embryonic stem (ES) cell lines derived from the epiblast tissue of
the inner cell mass of a blastocyst or earlier morula stage embryos
are pluripotent and can develop to the three primary germ layers:
ectoderm, endoderm and mesoderm. For that reason, human
embryonic stem (hES) cells represent an excellent clinical source of
precursor cells for cell-based therapy if they can be guided to
differentiate into a certain cell type needed to treat damaged
tissue in chronic diseases or injuries [1]. In addition to tissue
regeneration, hES cell derivatives can be used in studies of cellular
development, tumorigenesis, and in the discovery or cytotoxicity
screening of new drug candidates [2].
Different members of the Transforming Growth Factor b
(TGFb) family have been implicated in various developmental
stages and processes. One subfamily, the Bone Morphogenetic
Proteins (BMPs), have been traditionally studied with regard to
bone and cartilage development, but recently their effects have
been studied in mouse and human stem cell cultures [3]. Murine
and human stem cells display differences in their behavior upon
incubation with BMPs. BMP signaling promotes self-renewal in
mouse stem cells when incubated together with Leukemia
Inhibitory Factor in the absence of serum replacement or
conditioned medium [4]. In contrast, inhibition of BMP signaling
is a requirement for long term maintenance of hES cells [5], while
incubation with BMPs is a potent inductor of differentiation of
these cells in conditions that would otherwise support self-renewal
[6].
The diverse members of the BMP subfamily exert different
effects on hES cells. BMP-2 and BMP-6 have been involved in
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also known to induce extraembryonic endoderm differentiation of
hES cells [9]. BMP-4 has been linked to mesoderm and endoderm
formation, as well as kidney and bone development. In culture,
BMP-4 induces trophoblast differentiation of hES cells [10], and
endoderm differentiation of monkey stem cells [11].
From a structural point of view, the mature segment of the
BMPs is highly conserved in all organisms and contains seven
cysteine amino acid residues. Six of these residues are involved in
the formation of intrachain disulphide bonds that forms a rigid
‘‘cysteine-knot’’ molecular structure, and the seventh cysteine
residue is involved in the formation of a dimer via interchain
disulphide bond. BMPs interact with a pair of type II and type I
receptors (e.g. BMP receptor type Ia, BMPR1A; Activin receptor-
like kinase 1, ACVRL1; BMP receptor type 2, BMPR2; Activin
receptor type IIa, ACVR2A; Activin receptor type IIb, ACVR2B),
which are also respectively structurally conserved [12–14]. Most of
TGFb family ligands, including BMPs, are produced as either
homo- or heterodimers, increasing the variability of the effector
molecule. Although most studies in the past have been performed
with BMP homodimers, mainly due to their availability, there
are natural heterodimers with equal, if not increased, bioactivity
[15–19], and the heterodimer activity is not well elucidated yet.
We have recently established a procedure that allows us to
generate large quantity of BMP-2/BMP-6 heterodimer (BMP-2/6)
by a chemical refolding method [20]. This methodology enabled
us to study the activity of the BMP-2/6 heterodimer in a variety of
experiments that require sub-milligram amount of ligands. The
heterodimer showed a higher affinity to both receptor types than
its homodimeric counterparts, and increased SMAD1-dependent
signaling activity by luciferase reporter assay, osteogenic differen-
tiation-inducing activity in mouse MC3T3-E1 cells and chondro-
genic activity in primary cultured embryonic limb mesenchyme
[20]. To study its biological activity on hES cells, we have
compared BMP-2, BMP-6 and BMP-2/6 in inducing differenti-
ation of hES cells, quantified by gene expression analysis of specific
differentiation markers. We found that among BMP-2, BMP-6
and BMP-2/6, BMP-2/6 is more effective than BMP-2 or BMP-6
for inducing both trophoblast and endoderm differentiation of
hES cells H9. BMP-2/6 also induced higher levels of SMAD1/5
phosphorylation, and increased activation of Smad-independent
signaling pathways (ERK and p38 mitogen-activated protein/
MAP kinases) that might be related to its increased potency
for inducing hES cell differentiation. Our results support the
hypothesis of an enhanced biological activity of the BMP-2/6
heterodimer, and these characteristics make BMP-2/6 a good
candidate for its application in in vitro differentiation guidance of
human stem cells.
Results
BMP-2, BMP-6 and BMP-2/6 induce differentiation of hES
cells in a dose- and type-dependent manner
H9 cells were cultured in mTeSR1 (StemCell Technologies) on
Growth Factor-Reduced (GFR) Matrigel-coated wells (BD Biosci-
ences). Forty-eight hours (h) after splitting, hES cells were treated
with BMP-2, BMP-6 or BMP-2/6 at 100 ng/ml in mTeSR1 for 5
days, and the time course of morphological changes was analyzed.
Morphological changes were observed as soon as 24 h after
beginning incubation, and evident differentiation morphology
appeared usually after another 24 h.
Morphological changes induced by BMPs started synchronically
at the periphery of the colonies and spread towards the center.
Usually a central core of highly packed, morphologically
undifferentiated cells remained after 5 days of treatment
(Figure 1). In comparing this morphology to spontaneous
differentiation morphology, BMP-treated cells were usually bigger
and homogeneously shaped, while spontaneous differentiation
tended to be restricted to discrete spots, not synchronic and
morphologically heterogeneous (data not shown).
The time course of morphological changes depended on the
BMP ligand used as inductor of differentiation. BMP-2 and BMP-
2/6 at 100 ng/ml induced morphological changes after 24 h and
evident differentiation morphology of hES H9 cells after 48 h,
whereas the same concentration of BMP-6 only induced similar
morphological changes after an additional 24 h in comparison to
BMP-2 or BMP-2/6. There was no increased activity of BMP-2/6
when compared to BMP-2 in the number of differentiated
colonies, rate of differentiation or morphology. As expected,
noggin at 1 mg/ml completely blocked the morphological changes
induced by BMP-2 at 100 ng/ml (Figure 1E), which confirms that
the differentiation is BMP-dependent.
Lower concentrations of agonists (1 and 10 ng/ml) were also
tested. BMPs at 1 ng/ml did not induce any morphological
change on hES cell colonies after 5 days of incubation (data not
shown). BMP-2 or BMP-2/6 at 10 ng/ml induced morphological
changes, but with a delay of 24 h when compared to 100 ng/ml
(Figure 1F, 1H). BMP-6 at 10 ng/ml only elicited modest
morphological changes after 5 days, indicating again the lower
potency of BMP-6 to induce differentiation of H9 cells in our
culture conditions (Figure 1G). Based on morphological examina-
tion, BMP-2/6 heterodimer and BMP-2 homodimer are compa-
rably active, whereas BMP-6 homodimer is not as active.
Gene expression analysis of BMP-treated hES cells: BMP-2
and BMP-2/6 show similar activity to induce loss of
pluripotency markers
In order to examine the differentiation by BMP-2/6 with
molecular markers, we performed quantitative gene expression
analysis. After 5 days of incubation with BMPs at 100 ng/ml, total
RNA was extracted following the guanidinium thiocyanate-
phenol-chloroform protocol [21]. 5 mg of total RNA were used
for the reverse transcription reaction and gene expression was
analyzed by quantitative PCR (qPCR) with specific primers for
pluripotency or differentiation markers. We selected GAPDH as
housekeeping gene to perform the normalization of qPCR results
as GADPH expression is known to be less affected in hES cell
differentiation than other normalization standards [22]. All the
results were also normalized to non-treated H9 cells grown in
mTeSR1 (control conditions).
Consistent with the morphological change, expression of stem
cell markers NANOG and POU5F1/OCT4 were reduced in BMP-2-
treated H9 cells, and even more efficiently in BMP-2/6-treated H9
cells (Figure 2A, 2B). In contrast, expression of these markers was
not reduced in BMP-6 treated cells, despite the obvious
differentiation morphology in a significant percentage of cells
after 5 days (Figure 1C). Interestingly, BMP-6 induced an increase
in the expression of NANOG, which was potentiated by co-
incubation with noggin but not induced by noggin alone
(Figure 2A).
We also quantified the percentage of cells which lost the
embryonic stem cell marker TRA-1-60 (Figure 2C, 2D). H9 cells
were exposed to 100 ng/ml of BMP-2 or BMP-2/6 for 5 days, at
which point TRA-1-60 was tagged with an Alexa Fluor 488
conjugated antibody. Cells were analyzed by flow cytometry to
quantify the percentage of TRA-1-60-positive cells. We observed a
50% loss of TRA-1-60-positive pluripotent cells after BMP-2 or
BMP-2/6 treatment (Figure 2C), suggesting that differences in the
BMP-2/6 in hES Cells
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percentage of pluripotent cells.
Gene expression analysis of BMP-treated hES cells: BMP-2
and BMP-2/6 differ in their ability to induce the
expression of differentiation markers
Next, we examined markers for differentiation after 1, 3 and 5
days of BMP treatment. There were no significant variations in the
expression levels of NES/NESTIN (Figure 3A), which is a marker
of neural tissue. This confirms previous reports that activation of
BMP signaling blocks neuroectodermal differentiation of hES cells
[9,23,24].
We examined next trophectodermal markers CDX2 and CGB5/
HCG [25,26]. Expression of these markers was highly increased by
BMP-2 treatment, and this change was completely blocked by
noggin at 1 mg/ml (Figure 3B, 3C). BMP-6 also induced CDX2
expression, but no CGB5 expression. Interestingly, BMP-2/6 was
better inducer of CDX2 marker than BMP-2 or BMP-6 at any time
point analyzed, revealing an increased activity of the heterodi-
meric form in inducing trophoblast differentiation.
Expression of the early stage mesendodermal marker T (human
brachyury homolog) was induced by BMP-2, BMP-6 and BMP2/6
(Figure 3D). T was expressed in BMP-2 and BMP-6-treated cells at
the same level. Similar to the induction of trophectodermal
markers, BMP-2/6 showed stronger activity as inducer of this
marker. T is a hallmark of both definitive mesoderm cells as cells
undergoing meso-endoderm transition [27]. T expression peaked
after 3 days of treatment and decreased afterwards, which suggests
that its expression is mainly a prelude of endoderm differentiation.
Similar to the pattern of CDX2 expression, noggin at 1 mg/ml
completely blocked T expression induced by BMP-2, but only
partially blocked theincrease inducedby BMP-2/6(Figure 3B,3D).
Gene expression analysis of BMP-treated hES cells: BMP-
2/6 shows stronger activity to induce endodermal marker
expression
Given the strong induction of T, an early mesendodermal
marker, we further characterized the differentiation induced by
BMPs by the analysis of endodermal markers. SOX17 and CXCR4
are markers of definitive endoderm systematically used in studies
of endoderm differentiation [28–30]. Nevertheless, SOX17 can also
be expressed in extraembryonic endoderm, and CXCR4 can also
be expressed in mesendoderm cells, so a combination of several
markers is the best choice when definitive endoderm needs to be
accurately quantified. GATA4, GATA6 and AFP are extraembry-
onic endodermal markers [31], and AFP is also a marker of hepatic
differentiation of hES cells [32].
The pattern of expression of the endodermal markers SOX17,
GATA4, GATA6 and AFP indicated that BMP-2/6 is an effective
inducer of these markers and BMP-6 is not (Figure 4A-D).
Expression of SOX17, GATA4 and GATA6 showed a strong
induction under our conditions (500 to 1000 times GAPDH
expression), while expression of AFP showed a modest level of
induction. From these results we conclude that BMP-2/6 is a more
efficient inductor of endodermal differentiation than BMP-2 in our
experimental paradigm.
We also analyzed the expression of several members of the BMP
signaling pathway: agonists (BMP2, BMP6) and receptors
(BMPR1A/ALK3, BMPR1B/ALK6, BMPR2, ACVR1/ALK2,
ACVR2A, ACVR2B). Expression of BMP2 gene was induced by
BMP-2 and BMP-2/6 treatment, suggesting a positive feedback in
the BMP signaling pathway (Figure 4E). BMP2 is also a mesoderm
marker, indicating that BMP-2 and BMP-2/6 could also induce
modest levels of mesoderm differentiation. Expression of type II
receptor BMPR2 was also increased in all the conditions, but
Figure 1. Morphological changes of hES cells after treatment with BMPs. H9 cells were treated with BMP-2, BMP-6 or BMP-2/6 in mTeSR1 for
5 days. Noggin 1 mg/ml was used as antagonist to BMP-2. Medium was changed daily for fresh medium supplemented with the desired
concentration of agonists. Pictures were taken using an inverted microscope and 10X objective. A, control cells in mTeSR1. B, BMP-2 100 ng/ml. C,
BMP-6 100 ng/ml. D, BMP-2/6 100 ng/ml. E, BMP-2 100 ng/ml + noggin 1 mg/ml. F, BMP-2 10 ng/ml. G, BMP-6 10 ng/ml. H, BMP-2/6 10 ng/ml.
Arrowheads indicate morphologically pluripotent cells; arrows point out morphologically differentiated areas. Insets belong to 36magnification.
doi:10.1371/journal.pone.0011167.g001
BMP-2/6 in hES Cells
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(Figure 4F). The expression levels of BMPR1A, BMPR1B, ACVR1,
ACVR2A, ACVR2B and BMP6 were, however, not significantly
affected by any of the treatments (Figure S1). Therefore, these
results suggest that the positive feedback induced by BMP-2 or
BMP-2/6 comprises an increase in the expression of both agonist
(BMP2) and receptor (BMPR2).
With these results combined, we conclude that BMP-2, BMP-6
and BMP-2/6 induce mainly trophoblast and endoderm differen-
tiation in our experimental conditions. These BMPs also regulate
the expression of BMP2 and BMPR2 genes, suggesting the
possibility of a positive feedback of stimulation of BMP-2 signaling
pathway. The level of expression of selected genes (endodermal
SOX17, GATA6, GATA4, AFP and BMP signaling members BMP2
or BMPR2) can be used as a measure of the biological activity of
different BMPs in H9 hES cells. It is interesting to note that BMP-
2/6 is a more effective inducer of expression of differentiation
markers than BMP-2 or BMP-6, even though it is a heterodimeric
assembly of BMP-2 and BMP-6, and BMP-6 is not an active
inducer of differentiation.
Gene expression analysis of BMP-treated hES cells: BMP-2
and BMP-2/6 differ in their ability to induce definitive
endoderm marker CXCR4
CXCR4 is a marker of definitive endoderm cells and a surface
receptor that has been used to purify this population of cells
without compromising their viability [33]. We decided to measure
CXCR4 gene expression levels and the percentage of the CXCR4-
Figure 2. Expression analysis of stem cell markers after treatment with BMPs. H9 cells were treated with BMP-2, BMP-6 or BMP-2/6 at
100 ng/ml in mTeSR1 for 5 days. Noggin 1 mg/ml was used as antagonist. After 5 days of treatment, qPCR and flow cytometry were used to analyze
expression of stem cell markers. qPCR values correspond to relative expression compared to GAPDH mRNA. As control, cells growing in mTeSR1 were
used. Treatments were repeated at least in three different experiments, and results are expressed as average 6 SD. A, qPCR analysis of NANOG
expression. B, qPCR analysis of POU5F1 expression. C, Flow cytometry analysis of the embryonic stem cell marker TRA-1-60. D, Flow cytometry
histogram corresponding to the results shown in C. (*) P,0.05 BMP-2 vs. BMP-2/6; (**) P,0.01 BMP-2 vs. BMP-2/6; (#)P ,0.05 control vs. BMP; (##)
P,0.01 control vs. BMP.
doi:10.1371/journal.pone.0011167.g002
BMP-2/6 in hES Cells
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BMP treatments. H9 cells were treated with BMP-2, BMP-6 or
BMP-2/6 at 100 ng/ml for 1, 3 and 5 days in mTeSR1, and RNA
was extracted and analyzed by qPCR. While the increase in the
expression of CXCR4 was modest compared to the increase of
extraembryonic endodermal markers, we observed stronger
activity of BMP-2/6 in inducing this marker than that of the
homodimers BMP-2 and BMP-6 (Figure 5A).
This increase in mRNA levels could not be directly correlated to
changes in the percentage of definitive endodermal cells. To
quantify the percentage of CXCR4-positive endoderm cells
present after incubation with BMPs, we used flow cytometry in
non-permeabilization conditions. H9 cells were exposed to 10 or
100 ng/ml of BMP-2, BMP-6 or BMP-2/6 for 5 days and
CXCR4 was targeted with a Phycoerythrin (PE) labeled antibody.
Cells were analyzed by flow cytometry and the percentage of
CXCR4-positive cells quantified (Figure 5B–D). As expected, the
percentage of CXCR4-positive cells depended on the BMP and its
concentration (Figure 5B). When incubated at 10 ng/ml, BMP-2
induced an average of 17.4% CXCR4-positive cells and BMP-2/6
induced 24.4%. When incubated at 100 ng/ml, BMP-2/6 also
induced the expression of CXCR4 in more cells that BMP-2
(42.3% and 33.3% respectively). Nevertheless, BMP-6 had
reduced differentiation potency when compared to BMP-2 and
BMP-2/6 (2.6% at 10 ng/ml and 13.6% at 100 ng/ml).
These results confirm that BMP-2/6 is better inducer of
definitive endoderm differentiation of H9 cells than BMP-2 or
BMP-6 when measured by the level of expression of endodermal
markers and percentage of CXCR4-positive cells. BMP-2/6
induced the expression of CXCR4 marker in 1.3 times more cells
Figure 3. qPCR expression analysis of differentiation markers after treatment with BMPs (I). H9 cells were treated with BMP-2, BMP-6 or
BMP-2/6 at 100 ng/ml in mTeSR1 for 1, 3 or 5 days. Noggin 1 mg/ml was used as antagonist. After 5 days of treatment, qPCR was used to analyze
expression of differentiation markers. qPCR values correspond to relative expression compared to GAPDH mRNA. As control, cells growing in mTeSR1
were used. Treatments were repeated at least in three different experiments, and results are expressed as average 6 SD. A, NES.B ,CDX2.C ,CGB5.D ,T.
(**) P,0.01 BMP-2 vs. BMP-2/6.
doi:10.1371/journal.pone.0011167.g003
BMP-2/6 in hES Cells
PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e11167Figure 4. qPCR expression analysis of differentiation markers after treatment with BMPs (II). H9 cells were treated with BMP-2, BMP-6 or
BMP-2/6 at 100 ng/ml in mTeSR1 for 1, 3 or 5 days. Noggin 1 mg/ml was used as antagonist. After 5 days of treatment, qPCR was used to analyze
BMP-2/6 in hES Cells
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(average of 1.6 times). Those results confirm that BMP-2/6 is a
better inducer of endoderm differentiation than BMP-2 by a factor
of 30–60% in this model system.
Signaling pathways analysis of BMP treated hES cells:
BMP-2/6 is a better inductor of Smad-dependent and
Smad-independent signaling
Finally, we analyzed the involvement of different signaling
pathways in the early stages of BMP-2, BMP-6 and BMP-2/6-
induced differentiation of hES cells. Activation of BMP receptors
leads to the recruitment and phosphorylation of the receptor
regulated Smads (R-Smads) SMAD1, SMAD5 or SMAD8, that in
complex with SMAD4 migrate into the nucleus and activate the
transcription of specific target genes [34–36]. But BMPs and other
TGFb family members also activate a multitude of intracellular
signaling pathways in addition to Smads to regulate cell function,
including MAP kinases [34,37,38].
H9 cells were treated with BMP-2, BMP-6 or BMP-2/6 at
100 ng/ml for 5, 10, 30, 60 or 120 min in mTeSR1, and protein
was extracted and analyzed by immunoblotting (Figure 6).
Antibodies against phosphorylated (active) and total forms of
different members of Smad-dependent and Smad-independent
Figure 5. Expression analysis of endodermal marker CXCR4 in hES cells treated with BMPs. H9 cells were treated with BMP-2, BMP-6 or
BMP-2/6 in mTeSR1 for 1, 3 or 5 days. Noggin 1 mg/ml was used as antagonist. After 5 days of treatment, qPCR and flow cytometry were used to
analyze expression of the endodermal marker CXCR4. qPCR values correspond to relative expression compared to GAPDH mRNA. As control, cells
growing in mTeSR1 were used. Treatments were repeated at least in three different experiments, and results are expressed as average 6 SD. A, qPCR
analysis of CXCR4 expression. B, Flow cytometry analysis of CXCR4 after incubation with BMP-2, BMP-6 or BMP-2/6 at 10 or 100 ng/ml. C, D, Flow
cytometry histograms of CXCR4-positive cells after incubation with BMPs at 10 (C) or 100 ng/ml (D). As negative controls, untreated cells (TeSR) and
PE-conjugated mouse IgG2a isotype control (isotype) were used. (*) P,0.05 BMP-2 vs. BMP-2/6.
doi:10.1371/journal.pone.0011167.g005
expression of differentiation markers. qPCR values correspond to relative expression compared to GAPDH mRNA. As control, cells growing in mTeSR1
were used. Treatments were repeated at least in three different experiments, and results are expressed as average 6 SD. A, SOX17.B ,GATA4.C ,
GATA6.D ,AFP.E ,BMP2.F ,BMPR2. (*) P,0.05 BMP-2 vs. BMP-2/6; (**) P,0.01 BMP-2 vs. BMP-2/6; (***) P,0.001 BMP-2 vs. BMP-2/6; (#)P ,0.05 control
vs. BMP; (##)P ,0.01 control vs. BMP; (###)P ,0.001 control vs. BMP.
doi:10.1371/journal.pone.0011167.g004
BMP-2/6 in hES Cells
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induced SMAD1/5 phosphorylation in a time dependent manner.
BMP-2/6 induced higher levels of SMAD1/5 phosphorylation
than BMP-2 or BMP-6 after 1–2 h of treatment, while BMP-6 was
the less potent activator at any time point (Figure 6).
Next we analyzed activation of MAP kinase pathways by BMPs.
Levels of phosphorylated ERK (pan ERK) increased after 30 min
of treatment with BMPs (Figure 6), and BMP-2/6 strongly induced
ERK activation when compared to the homodimers BMP-2 and
BMP-6. This effect could also be observed in the case of p38 MAP
kinase, a known member of BMP Smad-independent signal-
ing cascades. After 2 h of treatment, both proteins remained
phosphorylated at high levels (Figure 6). On the contrary,
phosphorylation of SAPK/JNK was similar in BMP-2 and
BMP-2/6 treated cells and started decreasing after 30–60 min of
treatment (Figure 6).
Therefore the BMP-2/6 heterodimer induced higher levels of
SMAD1/5 phosphorylation and it is also a more potent activator
of Smad-independent signaling pathways than the homodimeric
forms BMP-2 or BMP-6, and these properties might be related to
its increased potency for inducing differentiation of hES cells.
FGF2 and TGFb1 components of the culture medium
affect how hES cells respond to BMP treatment
TeSR1 medium is characterized by high concentration of FGF2
(100 ng/ml) to inhibit cell differentiation and promote self-renewal
and pluripotency [39]. FGF2 is known to indirectly inhibit BMP
signaling and, therefore, a lower concentration or absence of
FGF2 would theoretically enhance the BMP-induced response.
Furthermore, Transforming Growth Factor b1 (TGFb1) (0.6 ng/
ml) present in mTeSR1 activates SMAD2/3 pathway to help
maintain hES cells in a proliferative state [40]. SMAD2/3 is
known to form a complex with SMAD4, which is also a
component of BMP-induced SMAD1/5/8 pathway, thus poten-
tially interfering with BMP-induced differentiation [40]. In order
to examine if BMP-induced differentiation of hES cells is affected
by FGF2 and TGFb1 present in the culture medium, we planned
to test whether depletion of FGF2 and TGFb1 would affect
the percentage, speed or amount of differentiation to a particular
fate in our culture conditions, using BMPs as inducers of
differentiation.
Cells were split in mTeSR1 and incubated with a modified
composition of mTeSR1 starting 24 h after splitting. The standard
mTeSR1 culture medium, containing both FGF2 and TGFb1a s
described above, was modified to a composition lacking FGF2 or
lacking both FGF2 and TGFb1. Cells were maintained in these
modified composition media for a total of 9 days, including a
splitting process at day 4 of incubation. Treatments with BMPs in
modified composition mTeSR1 started at day 5 of incubation in
modified composition media and lasted for 4 days.
After 4 days of incubation in FGF2-free medium, the effect of
FGF2 depletion was observed as a change in the morphology of
the colonies (star-shaped instead of rounded) and lower cell density
(Figure 7B). When the colonies were split in FGF2-free medium,
an elevated percentage of differentiated cells were observed in the
following days (Figure 7C), to the point that cells cultured in
FGF2-free mTeSR1 were unable to maintain pluripotency for
more than two passages. Treatment with BMP-2 or BMP-2/6 at
100 ng/ml in FGF2-free medium for 4 days exacerbated
differentiation triggered by the medium itself (Figure 7E, 7F),
while treatment with Activin A at 100 ng/ml completely blocked
differentiation (Figure 7D).
POU5F1 expression was reduced by 50% after 9 days of
incubation in FGF2-free medium and by 90% if the incubation
was performed in FGF2/TGFb1-free medium (Figure 8A).
Incubation of H9 cells in FGF2-free or FGF2/TGFb1-free media
did not induce the expression of high levels of any of the
differentiation markers analyzed, although differentiation was
evident at the end of the treatment (Figure 7, Figure 8). We only
detected an increased expression of BMP2 in modified composi-
Figure 6. Activation of Smad-dependent and Smad-independent signaling pathways by BMPs in hES cells. H9 cells were treated with
BMP-2, BMP-6 or BMP-2/6 at 100 ng/ml in mTeSR1 for 5, 10, 30, 60 and 120 min, or with mTeSR1 for 120 min (Control). Cell lysates were
immunoblotted using different antibodies for phosphorylated (p-, active) and total forms of transcription factors or MAP kinases. b-actin was used as
loading control.
doi:10.1371/journal.pone.0011167.g006
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TGFb1 are acting as anti-apoptotic, proliferative and pluripotency
maintenance factors, but not inhibiting endogenous BMP-induced
differentiation into ectodermal and endodermal lineage.
Next, we tested the differentiation-inducing activity of BMPs in
these culture conditions. H9 cells cultured for 5 days in FGF2-free
or FGF2/TGFb1-free media were exposed to BMP-2 or BMP-2/6
at 100 ng/ml for 4 subsequent days in the modified composition
media. When cells were treated with BMP-2 or BMP-2/6 after 5
days of FGF2 or FGF2/TGFb1 depletion, the effect of those
BMPs was characterized by an increased inhibition of POU5F1
expression (Figure 8A); however, the expression of trophectoder-
mal and endodermal markers was drastically abolished (Figure 8B–
D). With the only exception of AFP marker (Figure 8E), BMP-2/6
and BMP-2 exerted the same effect on hES cells cultured in FGF2-
free medium.
These results were confirmed by flow cytometry for the
endodermal marker CXCR4 (Figure 9). When incubated in a
FGF2/TGFb1-free medium, BMP-2 or BMP-2/6 diminished the
percentage of CXCR4-positive cells, both at 10 ng/ml (Figure 9A)
and at 100 ng/ml (Figure 9B) concentration. Therefore depletion
of FGF2 in mTeSR1 did not enhance differentiation-inducing
properties of BMP-2 or BMP-2/6, nor accentuated differences
between them. These results suggest that FGF2, rather than block,
synergistically acts with BMP signaling on the early stages of
differentiation of hES cells to trophoblast and endoderm
derivatives.
In light of the experimental results presented here, we can
conclude that BMP-2/6 is a better inductor of differentiation of
hES cells than BMP-2, and it’s a good candidate for differenti-
ation-guidance molecule. Furthermore, we demonstrate that
FGF2 can directly regulate BMP-induced differentiation in vitro.
Discussion
hES cells constitute a valuable model system in developmental
studies and in the search for new regenerative therapies. Various
stem cell types utilize BMP signals in a multitude of ways in order
to define their fates [41]. BMPs are known to be involved in
several types of differentiation processes and the use of BMPs in
differentiation of pluripotent cells is a powerful tool in biological
and medical research [32,42]. The development of new molecules
with increased activity is, therefore, a priority in medical and
pharmaceutical research. The use of these BMPs with increased
activity would permit the development of more efficient protocols
and increase the productivity of the existent ones.
In this line of investigation, increased activity of BMP
heterodimers has been previously reported; co-expression of
BMP-2 with BMP-6 or BMP-7 yields heterodimeric BMPs with
a specific activity about 20-fold higher than BMP homodimers in
in vitro alkaline phosphatase induction assay, and 5- to 10-fold
more potent than BMP-2 in inducing cartilage and bone in an in
vivo assay [15,19]. Other heterodimers, as BMP-4/7 or BMP-7/
GDF-7, also showed enhanced and/or novel properties in the
context of embryo development [16–18]. Therefore, BMP
heterodimers could be used as a natural choice for substituting
BMP homodimers in in vitro or in vivo assays. The production of
BMP heterodimers in an Escherichia coli cell expression system and
subsequent chemical refolding in vitro allowed us to work with high
concentrations of purified protein while avoiding the low yield
problems associated with a mammalian cell expression system
[20].
The BMP-2/6 heterodimer consists of one BMP-2 and one
BMP-6 subunit. Our experiments confirm the increased activity of
BMP-2/6 heterodimer relative to the homodimeric counterparts
Figure 7. Morphological changes of hES cells after treatment with BMPs in FGF2-free mTeSR1. H9 cells were split in regular mTeSR1 and
changed to FGF2-free mTeSR1 24 h after splitting. After 4 days of growing in modified composition media, colonies were split in FGF2-free mTeSR1
and incubated for other 5 days (total of 9 days). Treatments with BMP-2 or BMP-2/6 at 100 ng/ml started 24 h after splitting and lasted for 4 days.
Pictures were taken using an inverted microscope and 10X objective. A, control cells after 9 days of culture in mTeSR1. B, Incubation in FGF2-free
medium ((-)FGF2) for 4 days. C, Incubation in (-)FGF2 for 9 days. D, Treatment with 100 ng/ml Activin A in (-)FGF2 for 9 days. E, Treatment with
100 ng/ml BMP-2 in (-)FGF2 for 4 days. F, Treatment with 100 ng/ml BMP-2/6 in (-)FGF2 for 4 days. Arrowheads indicate morphologically pluripotent
cells; arrows point out morphologically differentiated areas. Insets belong to 36magnification.
doi:10.1371/journal.pone.0011167.g007
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were split in regular mTeSR1 and changed to modified composition media 24 h after splitting. After 4 days of growing in modified composition
media, colonies were split in the same modified composition medium and incubated for other 5 days (total of 9 days). Treatments with BMP-2 or
BMP-2/6 at 100 ng/ml started 24 h after splitting in modified composition media and lasted for 4 days. qPCR was used to analyze expression of stem
cell and differentiation markers. qPCR values correspond to relative expression compared to GAPDH mRNA. As control, cells growing in regular or
modified composition mTeSR1 were used. Treatments were repeated at least in three different experiments, and results are expressed as average 6
SD. A, POU5F1.B ,CDX2.C ,SOX17.D ,GATA6.E ,AFP.F ,BMP2. (*) P,0.05 BMP-2 vs. BMP-2/6; (**) P,0.01 BMP-2 vs. BMP-2/6; (***) P,0.001 BMP-2 vs.
BMP-2/6; ns, no significative difference BMP-2 vs. BMP-2/6; (###)P ,0.001 control vs. BMP-2/6.
doi:10.1371/journal.pone.0011167.g008
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heterodimeric forms are likely to have natural biological functions.
Previously BMP-2/7 heterodimer failed to exert an increased
effect on hES cells growing on MEFs when compared to BMP-2
[9], indicating that culture conditions and/or conditioned media
could play an important role in determining the fate of BMP-
differentiated cells.
BMP-2 and BMP-6 are both inducers of osteogenesis in human
mesenchymal stem cells [7,8] and endogenous BMP-2 and BMP-6
cooperatively play pivotal roles in bone formation under both
physiological and pathological conditions [43]. Nevertheless, type
I and type II receptor utilization differs significantly between
BMP-2/BMP-4 and BMP-6/BMP-7. BMP-4 is known to bind
to BMPR1A and/or BMPR1B, whereas BMP-6 and BMP-7
preferentially bind to ACVR1 [44]. Also a greater reliance of
BMPR2 is observed for BMP-2 (or BMP-4) relative to BMP-6 (or
BMP-7), whereas ACVR2A is more critical to BMP-6 for signaling
[45]. Unlike the homodimers, we recently reported that BMP-2/6
heterodimer exhibits a relatively high affinity for each receptor
type extracellular domain (ECD) as measured by surface plasmon
resonance [20]. Correlated to this, in several in vitro experiments
we have observed stronger activity of BMP-2/6 than that of BMP-
2 or BMP-6 [20]. Thus, the more potent inducer activity of BMP-
2/6 on hES cells is also likely derived from higher affinity to both
type I and type II receptors. In the present study we have observed
an increased expression of BMPR2 that could be responsible for
the stronger effect of BMP-2 when compared to BMP-6.
For differentiation analysis we used a combination of markers of
the three embryonic layers: ectoderm, mesoderm and endoderm.
None of the BMPs we examined exclusively direct differentiation
to only one cell type, but rather alter the relative proportions
of a specific cell type. By quantification of the expression of
differentiation markers, we identified BMP-2/6 as a better inducer
of trophoblast and endoderm differentiation of hES cells than
BMP-2 or BMP-6. BMP-2/6 is more effective than either BMP-2
or BMP-6 in inducing the expression of trophectodermal (CDX2),
mesendodermal (T), and endodermal (SOX17, GATA6, AFP,
CXCR4) markers, including the expression of BMPR2 receptor.
These results support an increased bioactivity of BMP-2/6 in the
described stem cell culture system, and it is being confirmed using
other hES cell lines.
The increase in CDX2 expression indicates trophectodermal
differentiation and suggests that in feeder-free conditions BMP-2
induces trophoblast, as observed previously with BMP-4 [46].
Markers of endoderm (both extraembryonic and definitive) were
also strongly induced. The definitive endoderm forms during
gastrulation and replaces the extraembryonic visceral endoderm.
Definitive endoderm is the precursor of several organs (pancreas,
liver) and in vitro differentiation to those cell types is of great use in
medical and biological studies. To generate definitive endoderm,
100 ng/ml of Activin A has been traditionally used in uncondi-
tioned medium [33], revealing a central role of TGFb family
pathways on this type of differentiation. Feeder layer-free
conditions are also better systems for differentiation of hES cells
into definitive endoderm [30]. Our results demonstrate that the
heterodimer BMP-2/6 is better inductor of endodermal markers
than the BMP-2 homodimer, including definitive endoderm. It
suggests that BMP-2/6 could replace BMP-2 as the inductor in
protocols of BMP-2-guided differentiation in vitro.
BMP receptors are present on hES cells and BMP signaling can
induce expression of BMP ligands, forming a positive feedback
loop in cells from various species, including human [47].
Specifically, BMP-2 can induce its own expression in human
embryonic carcinoma cells [9]. Treatment of human pluripotent
cells with BMP-2 leads to the accumulation of transcripts for this
factor consistent with a positive feedback model [9], but an
increased level of BMP2 gene transcription in hES cells had not
been reported. In our experiments we observed an increased
expression of both BMP2 and the type II receptor BMPR2 in cells
treated with BMP-2 and BMP-2/6. Up-regulation of the
expression of both ligand and receptor is a strong evidence of a
positive feedback of BMP-2 signaling and differential induction of
BMPR2 could be also a factor in the increased biological activity of
BMP-2/6 in hES cells. These results should be confirmed in the
Figure 9. Expression analysis of endodermal marker CXCR4 in hES cells treated with BMPs in FGF2/TGFb1-free mTeSR1. H9 cells were
split in regular mTeSR1 and changed to FGF2/TGFb1-free mTeSR1 24 h after splitting. After 4 days of growing in modified composition media,
colonies were split in FGF2/TGFb1-free mTeSR1 and incubated for other 5 days (total of 9 days). Treatments with BMP-2 or BMP-2/6 at 100 ng/ml
started 24 h after splitting and lasted for 4 days. Flow cytometry was used to analyze expression of the endodermal marker CXCR4. As control, cells
growing in FGF2/TGFb1-free mTeSR1 (TeSR) were used. As negative control, PE-conjugated mouse IgG2a isotype control (isotype) was used. A, Flow
cytometry histograms of CXCR4-positive cells after incubation with BMPs 10 ng/ml. B, Flow cytometry histograms of CXCR4-positive cells after
incubation with BMPs 100 ng/ml. Bars indicate the percentage of CXCR4-positive cells in each condition.
doi:10.1371/journal.pone.0011167.g009
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BMPs play an important role during all stages of embryonic
development, and although only two major signaling pathways
have been characterized (p38 and Smad pathways), the BMP
signaling is complex and includes cross-talk with other major
signaling pathways and negative feedback mechanisms [34,48,49].
It has been reported that the initiation of Smad-dependent
and Smad-independent signaling by BMP-2 depends on BMP-
receptor complexes [37,50,51]. BMP-2/6 possesses a higher
affinity to both receptors type I and II than its homodimeric
counterparts [20], and this new biological property could be
responsible for the increased activation of Smad-dependent and
Smad-independent signaling observed. We detected increased
levels of SMAD1/5 phosphorylation induced by BMP-2/6, which
confirms the recent reports using diverse experimental models,
as luciferase reporter assay, osteogenic differentiation-inducing
activity and chondrogenic activity [20]. Furthermore, increases in
SMAD1 phosphorylation have been previously reported in the
early events of BMP-induced hES cell differentiation [9,40].
Further study of BMP-2/6-activated signaling pathways would be
necessary to fully understand its increased potency in hES cell
differentiation.
Fibroblasts secrete multiple growth factors, including FGFs,
TGFbs, Activins, Wnts and antagonists of BMP signaling [6]. Of
those, FGF2 has the greatest effect in promoting hES cell self-
renewal, interrupting BMP signaling either by preventing the
nuclear translocation of phosphorylated SMAD1 [52] or by
repressing SMAD1 activity in the nucleus [53]. Suppressed BMP
signaling remains a consistent hallmark of current methods of hES
cell culture. When we cultured H9 cells in a modified TeSR1
medium without FGF2, cells differentiated quickly after splitting
and this differentiation was not blocked by noggin (data not
shown), but blocked by 100 ng/ml Activin A, suggesting a
compensatory effect due to the activation of the SMAD2/3
pathway [54]. Depletion of FGF2 has a more drastic effect than
TGFb1, as FGF2 is also involved in cell proliferation [46] and
trace levels of TGFb1 are present in Growth Factor-Reduced
Matrigel coating. Our results confirm that both FGF2 and TGFb1
in mTeSR1 are necessary for long term maintenance of H9 cells in
mTeSR1. Further analysis of this involvement should be
performed to improve and manipulate BMP-directed differentia-
tion of hES cells in vitro.
FGF2 depletion also affected BMP-2 and BMP-2/6-induced
differentiation by diminishing levels of expression of all the
differentiation markers analyzed, both trophectodermal and
endodermal. Presence of FGF2 was necessary for driving BMP-2
or BMP-2/6-induced differentiation to endoderm in mTeSR1.
When FGF2 was absent in mTeSR1, however, morphological
differentiation appeared but the pattern of expression of
differentiation markers after incubation with BMP-2 or BMP-2/
6 completely changed. We hypothesize that FGF2 inhibition of
neural differentiation could be a requirement for efficient BMP-
induced differentiation to endoderm. Further investigation in this
sense is required to clarify the involvement of FGF2 in BMP-
induced differentiation in mTeSR1.
We analyzed the biological activity of BMP-2/6 for inducing
differentiation of hES cells by measuring the expression of
differentiation markers using qPCR and flow cytometry. Both
BMP-2 and BMP-6 induce differentiation of hES cells, but the
heterodimer BMP-2/6 is a more efficient inductor of expression
of differentiation markers and percentage of CXCR4-positive
definitive endoderm cells. It suggests that BMP-2/6 is a better
candidate than BMP-2 as inductor in protocols of BMP-2-guided
differentiation in vitro, as well as possible applications of BMP-2/6
to treat bone injury substituting BMP-2 as active molecule.
Materials and Methods
Human embryonic stem cell culture
hES cell line H9 (WiCell, WI) was cultured in mTeSR1
(StemCell Technologies) on Growth Factor-Reduced Matrigel
(BD Biosciences) following the established protocol [55]. When
colonies reached 80–90% confluence, they were detached of the
plates with dispase 2 mg/ml in DMEM/F12 (1:1) (Invitrogen),
washed with DMEM/F12 and then scrapped in mTeSR1 and split
1:4 to 1:6 in Matrigel coated wells. Medium was changed daily for
fresh mTeSR1. For experiments, passages 40–60 were used.
Protein expression and purification
The mature domains of human BMP-2 (residues 1–110), human
BMP-6 (residues 1–132) and noggin were expressed in Escherichia
coli as inclusion bodies. The expressed inclusion bodies were
isolated, purified, and refolded using a modified protocol
[12,20,56,57]. The refolded BMP-2 and BMP-6 homodimers and
BMP2/BMP6 heterodimer were purified using a HiTrap heparin
column (GE Healthcare, Uppsala, Sweeden) and reversed phase
chromatography (GraceVydac, Deerfield, IL). The ligands were
lyophilized and resuspended in 10 mM HCl and stored at 280uC
(supplied by joint Protein Central, http://www.jointproteincentral.
com). After thawing, compounds can be stored at 4uC for one week
to one month. The biological activity of media supplemented with
BMPs was not affected after storage at 4uC for one month.
Treatment with agonists and modified media
For treatments in regular medium, mTeSR1 supplemented with
the desired concentration of agonists (1–100 ng/ml) was prepared,
filtered and daily added to the culture. For modified composition
media, mTeSR1 was prepared as previously reported [55] by
mixing all its components but the ones to be depleted. This
medium was supplemented with human recombinant FGF2
(Invitrogen) and/or TGFb1 (R&D Systems) if necessary for
control condition. Pictures were taken using an Olympus IX51
inverted microscope and QuantiFire XI Cooled Digital CCD
Camera and processed using PictureFrame software.
RNA extraction and reverse transcription reaction
Total RNA was extracted following the guanidinium thiocya-
nate-phenol-chloroform protocol [21] using TRIzol reactive
(Invitrogen). 5 mg of total RNA were used for reverse transcription
reaction, and mRNA was converted to complementary DNA
(cDNA) using oligo dT primers and Superscript II reverse
transcriptase (Invitrogen). For qPCR analysis 2 ml of total cDNA
were diluted in 90 mlo fH 2O, and 4 ml of this dilution were used in
each reaction.
Quantitative PCR (qPCR) analysis
Primers for qPCR were designed using Primer3 software [58] to
yield a 75–150 bp product, 20 bp long and Tm 60uC. Sequences
of primers, location, Tm and GC% are available in Table 1.
PCR reactions were prepared in microamp optical 96-well
reaction plates (Applied Biosystems). 4 ml of a 1:45 dilution of total
cDNA were mixed with 5 ml SYBR green PCR master mix 2X
(Roche) and 1 mM of each primer pair in a total volume of 10 ml.
Reactions were run in an ABI Prism 7900 Sequence Detector
(Applied Biosystems) and results analyzed with SDS2.3 software
(Applied Biosystems) for Ct calculations. Calculations of DDCt
values were performed following specifications of the manufacturer.
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H9 cells were treated with BMP-2, BMP-6 or BMP-2/6 at
10 ng/ml or 100 ng/ml for 5 days and then digested into
individual cells with TrypLE (Sigma) diluted 1:4 in PBS
(Invitrogen) for several minutes at 37uC. Cell suspension was
incubated with fluorophore-tagged primary antibody or isotype
control in phosphate-buffered saline (PBS) with 2% fetal bovine
serum. For quantifying pluripotent embryonic stem cells, Alexa
Fluor 488 mouse anti-human TRA-1-60 (BD Biosciences) was used.
For labeling definitive endoderm cells, Phycoerythrin (PE)-conju-
gated mouse monoclonal anti-human CXCR4 (R&D Systems) or
PE-conjugated mouse IgG2a isotype control (eBioscience) were
used. Cells were sorted using a Becton-Dickinson FACScan
analytical flow cytometer and data were analyzed with FlowJo
software.
Immunoblot analysis
H9 cells treated with BMP-2, BMP-6 or BMP-2/6 at 100 ng/
ml for 5, 10, 30, 60 or 120 min were washed with PBS, and
solubilized in RIPA buffer containing 50 mM Tris-HCl pH7.5,
150 mM NaCl, 1% NP-40, 0.1% SDS and 0.5% sodium
deoxycholate. Lysates were subjected to SDS-gel electrophoresis,
and proteins were electrotransferred to polyvinylidene difluoride
membranes and immunoblotted with specific antibodies. All the
antibodies used were from Cell Signaling Technologies (1:1000),
except anti-ERK (pan ERK) from BD Transduction Laboratories
(1:20000). Secondary HRP-conjugated antibodies were from
Bio-Rad. Labeled proteins were visualized using an enhanced
chemiluminescence detection system (Thermo Scientific).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5
software. One-way ANOVA and Bonferroni post-test were used to
compare multiple data sets, and t-Student test was used to
compare two data sets when necessary.
Supporting Information
Figure S1 qPCR expression analysis of BMP receptors and
agonist after treatment with BMPs. H9 cells were treated with
BMP-2, BMP-6 or BMP-2/6 at 100 ng/ml in mTeSR1 for 5 days.
After 5 days of treatment, qPCR was used to analyze expression of
BMP receptor and agonists. qPCR values correspond to relative
expression compared to GAPDH mRNA. As control, cells growing
in mTeSR1 were used. Treatments were repeated at least in three
different experiments, and results are expressed as average 6 SD.
A, BMPR1.B ,BMPR1B.C ,ACVR1.D ,ACVR2A.E ,ACVR2B.F ,
BMP6.
Found at: doi:10.1371/journal.pone.0011167.s001 (0.68 MB TIF)
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